retatrutide type 2 diabetes phase 2 results 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Phase 2 trial results demonstrate

Not to be used in foods, drugs, or medical diagnostics

For example, Ozempic and Mounjaro are approved for managing Type 2 diabetes , while Wegovy and Zepbound are specifically approved for weight loss

Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the global non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) registry

These questions reveal operational stability that affects your research reliability

Specific supplement ingredients with some evidence If you still want to explore supplementation alongside lifestyle changes, the ingredients with the strongest (though still limited) evidence for supporting GLP-1 include berberine (500-1500 mg daily), green tea extract containing EGCG, and curcumin with piperine for enhanced absorption

At the center of it all